CME
Evaluating Your Current Options in the Treatment of NSCLC with METex14 Skipping Mutations
November 02, 2022
Host: Paul Paik, MD Guest: Catherine Shu, MD Take a deep dive into current and ongoing clinical trials related to MET inhibitors and discover the key distinctions between these agents, such as dosing differences. Our experts also have recommendatio
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast
Gain access to Blubrry tools that help build your podcast, including free podcast stats!